157 related articles for article (PubMed ID: 37965529)
1. Peripheral Blood Th1/Th17 Immune Cell Shift is Associated with Disease Activity and Severity of AQP4 Antibody Sero-Positive Neuromyelitis Optica Spectrum Disorder.
Cao F; Wang Y; Wei R; Li C; Cheng Y; Zhou Y; Jin T; Zhang H; Lin L; Xu B
Neuropsychiatr Dis Treat; 2023; 19():2413-2421. PubMed ID: 37965529
[TBL] [Abstract][Full Text] [Related]
2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
[TBL] [Abstract][Full Text] [Related]
4. Analysis of LAP
Cai H; Liu Y; Dong X; Jiang F; Li H; Ouyang S; Yin W; He T; Zeng Q; Yang H
Neurol Sci; 2023 May; 44(5):1739-1747. PubMed ID: 36683084
[TBL] [Abstract][Full Text] [Related]
5. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder.
Ma X; Qin C; Chen M; Yu HH; Chu YH; Chen TJ; Bosco DB; Wu LJ; Bu BT; Wang W; Tian DS
J Neuroinflammation; 2021 Sep; 18(1):201. PubMed ID: 34526069
[TBL] [Abstract][Full Text] [Related]
7. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Schindler P; Grittner U; Oechtering J; Leppert D; Siebert N; Duchow AS; Oertel FC; Asseyer S; Kuchling J; Zimmermann HG; Brandt AU; Benkert P; Reindl M; Jarius S; Paul F; Bellmann-Strobl J; Kuhle J; Ruprecht K
J Neuroinflammation; 2021 May; 18(1):105. PubMed ID: 33933106
[TBL] [Abstract][Full Text] [Related]
8. The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab.
Nicolas P; Ruiz A; Cobo-Calvo A; Fiard G; Giraudon P; Vukusic S; Marignier R
Front Immunol; 2019; 10():2686. PubMed ID: 31803192
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder.
Hoshino Y; Noto D; Sano S; Tomizawa Y; Yokoyama K; Hattori N; Miyake S
J Neuroinflammation; 2022 Jan; 19(1):6. PubMed ID: 34991631
[TBL] [Abstract][Full Text] [Related]
10. Serum Aquaporin 4-Immunoglobulin G Titer and Neuromyelitis Optica Spectrum Disorder Activity and Severity: A Systematic Review and Meta-Analysis.
Liu J; Tan G; Li B; Zhang J; Gao Y; Cao Y; Jia Z; Sugimoto K
Front Neurol; 2021; 12():746959. PubMed ID: 34744983
[No Abstract] [Full Text] [Related]
11. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder.
Min W; Zhang L; Wang S; Xue M; Guo C; Zhu M
Mult Scler Relat Disord; 2023 Feb; 70():104517. PubMed ID: 36708681
[TBL] [Abstract][Full Text] [Related]
12. T follicular helper cells contribute to pathophysiology in a model of neuromyelitis optica spectrum disorders.
Yick LW; Ma OK; Chan EY; Yau KX; Kwan JS; Chan KH
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36649074
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte Subsets Are Associated with Disease Status in Neuromyelitis Optica Spectrum Disorders.
Yang H; Liu W; Wu YF; Zhu DS; Shen XF; Guan YT
Neuroimmunomodulation; 2022; 29(4):296-305. PubMed ID: 34903694
[TBL] [Abstract][Full Text] [Related]
14. Thymic Involution and Altered Naive CD4 T Cell Homeostasis in Neuromyelitis Optica Spectrum Disorder.
Chang H; Cong H; Wang H; Du L; Tian DC; Ma Y; Xu Y; Wang Y; Yin L; Zhang X
Front Immunol; 2021; 12():645277. PubMed ID: 34335563
[TBL] [Abstract][Full Text] [Related]
15. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J
JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547
[TBL] [Abstract][Full Text] [Related]
16. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.
Kaneko K; Sato DK; Nakashima I; Ogawa R; Akaishi T; Takai Y; Nishiyama S; Takahashi T; Misu T; Kuroda H; Tanaka S; Nomura K; Hashimoto Y; Callegaro D; Steinman L; Fujihara K; Aoki M
J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):927-936. PubMed ID: 29875186
[TBL] [Abstract][Full Text] [Related]
17. Association of Circulating Follicular Helper T Cells and Serum CXCL13 With Neuromyelitis Optica Spectrum Disorders.
Yang X; Peng J; Huang X; Liu P; Li J; Pan J; Wei Z; Liu J; Chen M; Liu H
Front Immunol; 2021; 12():677190. PubMed ID: 34335576
[TBL] [Abstract][Full Text] [Related]
18. Expansion of IL-6
Barros PO; Dias ASO; Kasahara TM; Ornelas AMM; Aguiar RS; Leon SA; Ruiz A; Marignier R; Araújo ACRA; Alvarenga R; Bento CAM
J Neuroimmunol; 2017 Jun; 307():82-90. PubMed ID: 28495144
[TBL] [Abstract][Full Text] [Related]
19. Th17 cells in neuromyelitis optica spectrum disorder: a review.
Lin J; Li X; Xia J
Int J Neurosci; 2016 Dec; 126(12):1051-60. PubMed ID: 26954363
[TBL] [Abstract][Full Text] [Related]
20. Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder.
Yuan C; Liu X; Cai S; Zhang L; Guo R; Jia Z; Sun Y; Li B
Mult Scler Relat Disord; 2023 Feb; 70():104504. PubMed ID: 36623394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
